. 2025 Sep 30;13(11):e01763-25. doi: 10.1128/spectrum.01763-25

TABLE 1.

Minimum inhibitory concentrations of 19 clinical MSSA isolates according to the broth microdilution method^a

	Minimum Inhibitory concentration (μg/mL)
	≤ 0.094 – ≥0.00625	≤ 0.25 – >0.094	≤1–0.25	≤2–1	4 – >2
CEF BMD	0/19 (0%)	6/19 (31.6%)	13/19 (68.4%)	0/19 (0%)	0/19 (0%)
CLI BMD	2/19 (10.5%)	17/19 (89.5%)	0/19 (0%)	0/19 (0%)	0/19 (0%)
LIN BMD	0/19 (0%)	0/19 (0%)	0/19 (0%)	12/19 (63.2%)	7/19 (36.8%)

^{^a}

CEF: cefazolin, CLI: clindamycin, LIN: linezolid, BMD: Broth Microdilution.